Publications by authors named "Sara Gomez-Armayones"
Background: Dupilumab has shown to be an effective and safe treatment for patients with moderate-to-severe atopic dermatitis (AD).
Objective: To evaluate the predictive factors of response (PRF) in patients with moderate-to-severe AD treated with dupilumab.
Methods: Observational, retrospective and multicentre study conducted on adult patients diagnosed with moderate-to-severe AD treated with dupilumab, with a post-treatment follow-up of at least 16 weeks.
Article Synopsis
- The study looked at how patients with chronic spontaneous urticaria (CSU) respond to a medicine called omalizumab and whether they still need to take antihistamines (AH).
- Some patients (23.5%) stopped taking AH while on omalizumab and had better results in controlling their symptoms.
- The researchers think more studies are needed to figure out which patients can stop taking antihistamines safely while using omalizumab.
Background: Human papillomavirus (HPV) is the cause of a fraction of head and neck squamous cell carcinoma. Although this relation is well-known, it is still not clear the role of HPV in premalignant oral lesions such as oral lichen planus (OLP) and dysplasia. We aimed to evaluate the HPV-DNA prevalence and type distribution in a set of oral biopsies obtained from patients diagnosed with OLP and dysplasia, as well as the role of HPV in these lesions.
View Article and Find Full Text PDF